These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2900891)

  • 21. VIP and its homologues increase vascular conductance in certain endocrine and exocrine glands.
    Huffman LJ; Connors JM; Hedge GA
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E435-42. PubMed ID: 3354661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro spontaneous motility of gastric smooth muscles of the sheep.
    Wong MH; McLeay LM
    Q J Exp Physiol; 1988 Jul; 73(4):521-31. PubMed ID: 2902654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hexamethonium and atropine on the basal levels of immunoreactive vasoactive intestinal polypeptide in dogs.
    Misawa T; Chijiiwa Y; Ibayashi H
    Gastroenterol Jpn; 1986 Dec; 21(6):579-83. PubMed ID: 2883064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-release of PHI and VIP in dog stomach by peripheral and central vagal stimulation.
    Ohta T; Ito S; Ohga A
    Br J Pharmacol; 1990 Jun; 100(2):231-6. PubMed ID: 2379030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural control of electrical gastric activity in response to inflation of the antrum in the rabbit.
    Deloof S; Rousseau JP
    J Physiol; 1985 Oct; 367():13-25. PubMed ID: 2865361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vagal control of the pyloric motor function: a physiological and immunohistochemical study in cat and man.
    Edin R
    Acta Physiol Scand Suppl; 1980; 485():1-30. PubMed ID: 6163319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory function of VIP-PHI and galanin in canine pylorus.
    Allescher HD; Daniel EE; Dent J; Fox JE
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G789-97. PubMed ID: 2468295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrinsic and intrinsic neural control of pyloric sphincter pressure in the dog.
    Allescher HD; Daniel EE; Dent J; Fox JE; Kostolanska F
    J Physiol; 1988 Jul; 401():17-38. PubMed ID: 2902218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of reticulo-ruminal motility by volatile fatty acids and lactic acid in sheep.
    Gregory PC
    J Physiol; 1987 Jan; 382():355-71. PubMed ID: 3625553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
    Gespach C; Hui Bon Hoa D; Rosselin G
    Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular effects of the peptides PYY and PHI: comparison with APP and VIP.
    Lundberg JM; Tatemoto K
    Eur J Pharmacol; 1982 Sep; 83(1-2):143-6. PubMed ID: 6897040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOS.
    Holle GE; Steinbach E; Wünsch E; Holst JJ
    Am J Physiol; 1995 Oct; 269(4 Pt 1):G584-90. PubMed ID: 7485511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioacceleration provoked by intrathecal administration of vasoactive intestinal peptide (VIP): mediation by a non-central nervous system mechanism.
    Rochford J; Henry JL
    Neuropeptides; 1989; 14(4):243-52. PubMed ID: 2482950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vaso-active intestinal polypeptide on systemic and splanchnic haemodynamics: role in vasodilation following mesenteric ischaemia.
    Somjen G; Fletcher DR; Shulkes A; Hardy KJ
    Digestion; 1988; 40(3):133-43. PubMed ID: 3234619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxytocin infusions increase plasma levels of insulin and VIP but not of gastrin in conscious dogs.
    Stock S; Uvnäs-Moberg K
    Acta Physiol Scand; 1985 Oct; 125(2):205-10. PubMed ID: 3907274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of local mechanism involvement in vasoactive intestinal polypeptide release from canine small intestine.
    Chijiiwa Y; Misawa T; Ibayashi H
    Gastroenterology; 1986 Jun; 90(6):1877-81. PubMed ID: 2870952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory and inhibitory effects of gastrin peptides on gastric motility in sheep.
    McLeay LM; Wong MH
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R388-95. PubMed ID: 2569839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cineradiography of the reticular groove mechanism.
    Newhook JC; Titchen DA
    Aust Vet J; 1976 Mar; 52(3):132-5. PubMed ID: 985242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.